Yong-Mi Kim, MD, PhD

Title(s)Professor of Pediatrics
SchoolKeck School of Medicine of Usc
AddressCHL MailStop57
Off Campus
Los Angeles CA 90089
Phone+1 323 361 8544
vCardDownload vCard

    Collapse Overview 
    Collapse Websites

    Collapse ORNG Applications 
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wnt Signaling in the Tumor Microenvironment. Adv Exp Med Biol. 2021; 1270:107-121. Ruan Y, Ogana H, Gang E, Kim HN, Kim YM. PMID: 33123996; PMCID: PMC8477804.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    2. Cadherins, Selectins, and Integrins in CAM-DR in Leukemia. Front Oncol. 2020; 10:592733. Kim HN, Ruan Y, Ogana H, Kim YM. PMID: 33425742; PMCID: PMC7793796.
      View in: PubMed   Mentions: 17  
    3. Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment. Int J Mol Sci. 2020 Aug 28; 21(17). Ruan Y, Kim HN, Ogana H, Kim YM. PMID: 32872365; PMCID: PMC7503842.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    4. Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia. Blood. 2020 07 09; 136(2):210-223. Gang EJ, Kim HN, Hsieh YT, Ruan Y, Ogana HA, Lee S, Pham J, Geng H, Park E, Klemm L, Willman CL, Carroll WL, Mittelman SD, Orgel E, Oberley MJ, Parekh C, Abdel-Azim H, Bhojwani D, Wayne AS, De Arcangelis A, Georges-Labouesse E, Wayner E, Bonig H, Minasyan A, Ten Hoeve J, Graeber TG, Müschen M, Heisterkamp N, Kim YM. PMID: 32219444; PMCID: PMC7357190.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    5. Characterizing the Motility of Chemotherapeutics-Treated Acute Lymphoblastic Leukemia Cells by Time-Lapse Imaging. Cells. 2020 06 16; 9(6). Liu HC, Gang EJ, Kim HN, Ruan Y, Ogana H, Wan Z, Bönig H, Shung KK, Kim YM. PMID: 32560076; PMCID: PMC7349263.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    6. CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression. Leukemia. 2021 01; 35(1):75-89. Fousek K, Watanabe J, Joseph SK, George A, An X, Byrd TT, Morris JS, Luong A, Martínez-Paniagua MA, Sanber K, Navai SA, Gad AZ, Salsman VS, Mathew PR, Kim HN, Wagner DL, Brunetti L, Jang A, Baker ML, Varadarajan N, Hegde M, Kim YM, Heisterkamp N, Abdel-Azim H, Ahmed N. PMID: 32205861; PMCID: PMC7519582.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimalsCells
    7. A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity. Nat Med. 2019 12; 25(12):1938-1947. Khan S, Zhang X, Lv D, Zhang Q, He Y, Zhang P, Liu X, Thummuri D, Yuan Y, Wiegand JS, Pei J, Zhang W, Sharma A, McCurdy CR, Kuruvilla VM, Baran N, Ferrando AA, Kim YM, Rogojina A, Houghton PJ, Huang G, Hromas R, Konopleva M, Zheng G, Zhou D. PMID: 31792461; PMCID: PMC6898785.
      View in: PubMed   Mentions: 220     Fields:    Translation:HumansAnimalsCells
    8. Integrin Antibody Decreases Deformability of Patient-Derived Pre-B Acute Lymphocytic Leukemia Cells as Measured by High-Frequency Acoustic Tweezers. J Ultrasound Med. 2020 Mar; 39(3):589-595. Liu HC, Gang EJ, Kim HN, Abdel-Azim N, Chen R, Abdel-Azim H, Shung KK, Kim YM. PMID: 31633840; PMCID: PMC7493593.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    9. Relapse-associated AURKB blunts the glucocorticoid sensitivity of B cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2019 02 19; 116(8):3052-3061. Poulard C, Kim HN, Fang M, Kruth K, Gagnieux C, Gerke DS, Bhojwani D, Kim YM, Kampmann M, Stallcup MR, Pufall MA. PMID: 30733284; PMCID: PMC6386662.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    10. Targeting PI3K Signaling in Acute Lymphoblastic Leukemia. Int J Mol Sci. 2019 Jan 18; 20(2). Sanchez VE, Nichols C, Kim HN, Gang EJ, Kim YM. PMID: 30669372; PMCID: PMC6358886.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    11. Characterizing Deformability of Drug Resistant Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells Using Acoustic Tweezers. Sci Rep. 2018 10 24; 8(1):15708. Liu HC, Gang EJ, Kim HN, Lim HG, Jung H, Chen R, Abdel-Azim H, Shung KK, Kim YM. PMID: 30356155; PMCID: PMC6200731.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    12. The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL. Cancers (Basel). 2017 Sep 10; 9(9). Adam E, Kim HN, Gang EJ, Schnair C, Lee S, Lee S, Khazal S, Kosoyan O, Konopleva M, Parekh C, Bhojwani D, Wayne AS, Abdel-Azim H, Heisterkamp N, Kim YM. PMID: 28891959; PMCID: PMC5615336.
      View in: PubMed   Mentions: 9  
    13. CBP/Catenin antagonists: Targeting LSCs' Achilles heel. Exp Hematol. 2017 08; 52:1-11. Kim YM, Gang EJ, Kahn M. PMID: 28479420; PMCID: PMC5526056.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    14. Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells. Methods Mol Biol. 2017; 1613:463-478. Duchartre Y, Kim YM, Kahn M. PMID: 28849572; PMCID: PMC7473415.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    15. Am80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortality. EMBO Mol Med. 2016 11; 8(11):1340-1359. Li L, Qi X, Sun W, Abdel-Azim H, Lou S, Zhu H, Prasadarao NV, Zhou A, Shimada H, Shudo K, Kim YM, Khazal S, He Q, Warburton D, Wu L. PMID: 27737899; PMCID: PMC5090663.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    16. The Wnt signaling pathway in cancer. Crit Rev Oncol Hematol. 2016 Mar; 99:141-9. Duchartre Y, Kim YM, Kahn M. PMID: 26775730; PMCID: PMC5853106.
      View in: PubMed   Mentions: 240     Fields:    Translation:HumansAnimalsCells
    17. Effects of the small-molecule inhibitor of integrin α4, TBC3486, on pre-B-ALL cells. Leukemia. 2014 Oct; 28(10):2101-4. Hsieh YT, Gang EJ, Shishido SN, Kim HN, Pham J, Khazal S, Osborne A, Esguerra ZA, Kwok E, Jang J, Bonig H, Biediger RJ, Vanderslice P, Kim YM. PMID: 24903479; PMCID: PMC4190402.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    18. Role of integrin alpha4 in drug resistance of leukemia. Front Oncol. 2014; 4:99. Shishido S, Bönig H, Kim YM. PMID: 24904821; PMCID: PMC4033044.
      View in: PubMed   Mentions: 49  
    19. Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy. Blood. 2013 Mar 07; 121(10):1814-8. Hsieh YT, Gang EJ, Geng H, Park E, Huantes S, Chudziak D, Dauber K, Schaefer P, Scharman C, Shimada H, Shojaee S, Klemm L, Parameswaran R, Loh M, Kang ES, Koo HH, Hofmann WK, Andrade J, Crooks GM, Willman CL, Müschen M, Papayannopoulou T, Heisterkamp N, Bönig H, Kim YM. PMID: 23319569; PMCID: PMC3591800.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansAnimalsCells